SCHEMBL700745

SCHEMBL700745

Cc1c(Br)ccc(S(C)(=O)=O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 1/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
EPAS1 Q99814 3/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
CCR2 P41597 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32
CA6 P23280 1/20 0.32
MAPK10 P53779 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29603298 1.00 L3MBTL1 (0.41) L3MBTL1ALDH1A1MEN1CYP1A2PKM
SCHEMBL17529293 0.84 L3MBTL1 (0.39) L3MBTL1ALDH1A1MEN1CYP1A2PKM
SCHEMBL29008152 0.84 TSHR (0.35) ALDH1A1MEN1CYP1A2PKMTSHR
SCHEMBL5638874 0.83 L3MBTL1 (0.42) L3MBTL1ALDH1A1PIK3CDPIK3CAPIK3CB
SCHEMBL5880820 0.82 CA2 (0.46) L3MBTL1ALDH1A1MEN1CYP1A2PKM
SCHEMBL30239389 0.82 CA2 (0.46) L3MBTL1ALDH1A1MEN1CYP1A2PKM
SCHEMBL7396658 0.81 L3MBTL1 (0.37) L3MBTL1ALDH1A1TSHRCYP2C19EPAS1
SCHEMBL27615202 0.81 L3MBTL1 (0.37) L3MBTL1ALDH1A1EPAS1PIK3CDPIK3CA
SCHEMBL9448525 0.81 CCR2 (0.40) L3MBTL1ALDH1A1EPAS1CCR2
SCHEMBL4541616 0.80 TRPV4 (0.36) ALDH1A1MEN1CYP1A2PKMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115385832-B Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene 江苏七洲绿色科技研究院有限公司 2024-04-30 CN claimed
CN-117110489-A Method for measuring content of topramezone intermediate 山东亿盛实业股份有限公司 2023-11-24 CN claimed
CN-115874202-A Method for producing sulfonyl compounds by electrolytic oxidation of thio compounds 华东理工大学 2023-03-31 CN claimed
CN-115385832-A Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene 江苏七洲绿色科技研究院有限公司 2022-11-25 CN claimed
CN-112094211-B Preparation method of topramezone intermediate 江苏七洲绿色化工股份有限公司 2022-04-29 CN claimed
CN-112694425-B Method for preparing topramezone intermediate by using supergravity reaction 利民化学有限责任公司 2022-04-26 CN claimed
CN-112694425-A Method for preparing topramezone intermediate by using supergravity reaction 利民化学有限责任公司 2021-04-23 CN claimed
CN-112321466-A Synthetic method of topramezone key intermediate 华东师范大学 2021-02-05 CN claimed
CN-112094211-A Preparation method of topramezone intermediate 江苏七洲绿色化工股份有限公司 2020-12-18 CN claimed
CN-118359520-A Preparation method of topramezone intermediate 山东亿盛实业股份有限公司 2024-07-19 CN disclosed
CN-115385832-B Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene 江苏七洲绿色科技研究院有限公司 2024-04-30 CN disclosed
CN-115385832-B Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene 江苏七洲绿色科技研究院有限公司 2024-04-30 CN disclosed
CN-115385832-B Preparation method of 2, 3-dimethyl 4-methylsulfonyl bromobenzene 江苏七洲绿色科技研究院有限公司 2024-04-30 CN disclosed
CN-114797738-B Improved tubular reactor, production equipment using the same, and method for producing sulfonyl compound using the same 兰升生物科技集团股份有限公司 2024-04-02 CN disclosed
US-20030018200-A1 Preparation of isoxazolin-3-ylacylbenzenes BASF SE (DE) 2003-01-23 US disclosed
US-6469176-B1 CROP PROTECTION COMPOUNDS BASF AKTIENGESELLSCHAFT (DE) 2002-10-22 US disclosed
EP-1129082-A1 METHOD AND NOVEL INTERMEDIATE PRODUCTS FOR PRODUCING ISOXAZOLIN-3-YL-ACYLBENZENES BASF AKTIENGESELLSCHAFT (DE) 2001-09-05 EP disclosed
EP-1077955-A1 METHOD FOR PRODUCING ISOXAZOLINE-3-YL-ACYL BENZENE BASF AKTIENGESELLSCHAFT (DE) 2001-02-28 EP disclosed
WO-2000029394-A1 METHOD AND NOVEL INTERMEDIATE PRODUCTS FOR PRODUCING ISOXAZOLIN-3-YL-ACYLBENZENES BASF AKTIENGESELLSCHAFT (DE) 2000-05-25 WO disclosed
WO-1999058509-A1 METHOD FOR PRODUCING ISOXAZOLINE-3-YL-ACYL BENZENE BASF AKTIENGESELLSCHAFT (DE) 1999-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030018200-A1 Preparation of isoxazolin-3-ylacylbenzenes CYP2F1, UQCRB, CYP1B1 L3MBTL1 2147/4885ALDH1A1 352/4885MEN1 3550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.